Professional
Added to YB: 2025-02-11
Pitch date: 2024-12-31
BDX [bullish]
Becton, Dickinson and Company
-10.35%
current return
Author Info
No bio for this author
Company Info
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide.
Market Cap
$57.3B
Pitch Price
$223.18
Price Target
N/A
Dividend
2.09%
EV/EBITDA
11.95
P/E
34.52
EV/Sales
3.51
Sector
Health Care Equipment and Supplies
Category
value
Oakmark Global All Cap Strategy New Position: Becton, Dickinson and Company
BDX: Global med tech leader w/ top market share across product lines. COVID-19, inflation masked portfolio & ops improvements. Opportunity to invest in above-avg business at below-avg valuation. Continuous innovation & manufacturing scale drive competitive advantage.
Read full article (1 min)